Neurotransmitter, receptor and signal transduction disturbances in Alzheimer's disease
- 1 September 1992
- journal article
- review article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 85 (S139), 59-62
- https://doi.org/10.1111/j.1600-0404.1992.tb04456.x
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Tacrine in Alzheimer's diseaseThe Lancet, 1991
- D1-Dopamine Receptor Abnormality in Frontal Cortex Points to a Functional Alteration of Cortical Cell Membranes in Alzheimer's DiseaseArchives of Neurology, 1990
- Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?The FASEB Journal, 1990
- The mechanism of tetrahydroaminoacridine‐evoked release of endogenous 5‐hydroxytryptamine and dopamine from rat brain tissue prismsBritish Journal of Pharmacology, 1989
- The Neuroanatomy of Alzheimer's DiseaseReviews in the Neurosciences, 1989
- Long-term effects of basal forebrain lesions on cholinergic, noradrenergic and serotonergic markers in mouse neocortexBrain Research Bulletin, 1988
- 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K+ currentEuropean Journal of Pharmacology, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Cholinergic function and intellectual decline in Alzheimer's diseaseNeuroscience, 1986
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976